Achalasia Clinical Trial
Official title:
Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
This study evaluates whether a medication called mirabegron is better than placebo (sugar pill) in helping patients with achalasia swallow better. Each patient will receive either mirabegron or the placebo for 4 weeks followed by the opposite medication. Each patient will complete several surveys and undergo several tests to determine if the mirabegron is helping reduce the pressures in the esophagus (swallowing tube).
Achalasia is characterized by incomplete or absent relaxation of the lower esophageal sphincter (LES) and loss of esophageal peristalsis which leads to dysphagia. Standard of care for achalasia includes endoscopic management (dilation and injection of injection of botulinum toxin) and surgery, however both of these options carry procedural risks, may lose efficacy over time and many patients are not appropriate candidates for these treatment options. Unfortunately, there are limited oral medications for patients with achalasia. Mirabegron is an oral beta-3 agonist currently FDA approved for overactive bladder that works by relaxing the bladder muscles. Beta-3 receptors have also been identified in the LES with stimulation leading to LES relaxation in preclinical studies. Through a proof of concept pilot study, the investigators aim to evaluate the effect of mirabegron in patients with achalasia via high resolution manometry and a validated dysphagia scale. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01399476 -
Endoscopic Myotomy of the Lower Esophageal Sphincter for Achalasia
|
N/A | |
Recruiting |
NCT05326113 -
The Effect of Physiotherapy on Post POEM Reflux
|
N/A | |
Recruiting |
NCT06044155 -
redoPOEM : Failure of a First POEM
|
||
Recruiting |
NCT02989883 -
Clinical Outcomes of Peroral Endoscopic Myotomy
|
N/A | |
Terminated |
NCT02606578 -
Achalasia Patient Reported Outcomes
|
||
Recruiting |
NCT01793922 -
POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)
|
N/A | |
Recruiting |
NCT01302288 -
Endolumenal Partial Myotomy for the Treatment of Esophageal Achalasia
|
Phase 2 | |
Terminated |
NCT03875365 -
Institutional Outcome Data From Per-oral Plication of the Esophagus
|
||
Enrolling by invitation |
NCT02770859 -
Per-Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia, Database Repository
|
||
Recruiting |
NCT05905016 -
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
|
||
Completed |
NCT01692106 -
A Clinical Study of Per Oral Endoscopic Myotomy (POEM) in Patients Suffering From Achalasia
|
N/A | |
Completed |
NCT01405469 -
Endoscopic Peroral Myotomy for Treatment of Achalasia
|
N/A | |
Completed |
NCT01402518 -
Per-Oral Endoscopic Myotomy
|
||
Not yet recruiting |
NCT00790465 -
Efficacy of Dark Chocolate in Achalasia Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT01799967 -
Minimally Invasive Surgery of the Gastro-esophageal Junction
|
||
Terminated |
NCT00604942 -
vMII for Measurement of Oesophageal Bolus Transport and Reflux
|
N/A | |
Recruiting |
NCT06405412 -
Effects of Malnutrition on Respiratory and Renal Functions in Patients Undergoing Peroral Endoscopic Myotomy (POEM)
|
N/A | |
Not yet recruiting |
NCT06042127 -
POEM-F for Achalasia International Study
|
N/A | |
Completed |
NCT04752670 -
ConMed Beamer Study
|
||
Completed |
NCT02314741 -
Peroral Endoscopic Myotomy (POEM) for Esophageal Motility
|
N/A |